Related Experiment Video
Updated: May 22, 2025

Description of a Swine Infant Model of Volume-Controlled Hemorrhagic Shock
Published on: November 3, 2023
Management of severe acute pulmonary haemorrhage in children
Alexander I Gipsman1, Lauren M C Grant1, Joseph C Piccione2
1Division of Pulmonary and Sleep Medicine, Children's Hospital of Philadelphia, Philadelphia, PA, USA.
Insights
Pediatric pulmonary hemorrhage management involves controlling bleeding and treating causes. This review covers recent evidence on medical, interventional, and surgical treatments for children with lung bleeding.
Area of Science:
- Pediatric Pulmonology
- Critical Care Medicine
- Pediatric Hematology
Background:
- Pulmonary hemorrhage in children is a serious condition with limited high-quality clinical trials.
- Current evidence relies heavily on observational data and adult studies.
- Effective management requires addressing bleeding control, source identification, and underlying causes.
Purpose of the Study:
- To review the latest evidence on managing pediatric pulmonary hemorrhage.
- To summarize medical, interventional, and surgical treatment options for children.
- To provide an updated resource for clinicians treating lung bleeding in pediatric patients.
Main Methods:
- Comprehensive literature search for recent studies on pediatric pulmonary hemorrhage treatments.
- Analysis of evidence regarding flexible bronchoscopy, medications, embolization, and surgery.
- Synthesis of findings to present current treatment strategies.
Main Results:
- Flexible bronchoscopy is crucial for diagnosis, intervention, and targeted medication delivery.
- Pharmacological treatments include vasoconstrictors, antifibrinolytics, and recombinant factor VIIa.
- Definitive treatments may involve immunomodulatory drugs, bronchial artery embolization, or surgery.
Conclusions:
- A multi-faceted approach is essential for managing pediatric pulmonary hemorrhage.
- Recent evidence supports various medical, interventional, and surgical modalities.
- Further research is needed to strengthen the evidence base for pediatric lung bleeding treatments.
Abstract:
Pulmonary haemorrhage is a potentially life-threatening condition with a variety of causes. Quality clinical trials are insufficient in children, restricting the evidence base to observational data and adult studies. The overall management strategy should address control of symptomatic bleeding, identification of the bleeding source, and treatment of the underlying cause. Flexible bronchoscopy is an important tool used to identify the cause and site of bleeding, do interventional procedures, and directly instil medications to affected areas. Medications to control bleeding include vasoconstrictors, antifibrinolytics, and recombinant factor VIIa. Definitive treatment often requires immunomodulatory medications, bronchial artery embolisation, or surgery. In this Review, we summarise the most recent evidence pertaining to medical, interventional, and surgical treatments of pulmonary haemorrhage in children.
Related Concept Videos
Acute Respiratory Failure-V
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Flail Chest-II
Assessment:
1. Clinical Evaluation:
History:
Esophageal Varices-II: Clinical Features and Management
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
Pneumothorax-I
Pneumothorax can be even further classified as spontaneous, traumatic, and tension pneumothorax.
Pneumothorax-II
Clinical Manifestations:

